North America Opioid Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report By 2024
“The North America Opioid Market is expected to value at USD 18.5 billion by 2024 at CAGR of 4.6% in the forecast period, providing numerous opportunities for market players to invest for research and development in the market.”
The North America Opioid Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The North America Opioid Market is expected to value at USD 18.5 billion by 2024. The North America opioid industry is subject to witness a substantial growth due to the rising geriatric population and growing focus towards palliative care for patient across the globe. Application of the opioid varies from analgesics drugs to cough suppressants and as anti-diarrheal medicines. Top Companies: Countries such as U.S., Canada and Mexico are leading the North America market with rising geriatric population, increasing awareness regarding palliative care services, growing number of medical facilities, and significant investment by leading industry players considering potential growth opportunities in the region. The key players in the North America opioid market are Purdue Pharma L.P., Allergan plc (Actavis), Pfizer, Inc., Janssen Pharmaceuticals, Inc., and Egalet Co. Growth Drivers: Growing occurrence of incidences related to excessive use of opioid medication due to their unique set of properties, particularly influential in palliative care, is expected to drive their sales output. Furthermore, factors positively affecting market performance of opioid industry in North America region include rising penetration of generics technology and increasing healthcare expenditure levels by local governments.
Moreover, higher approval rate from local authorities such as The Food and Drug Administration (FDA) coupled with the availability of a strong drug pipelines are excepted to boost market growth over the forecast period. Availability improved, efficacious drugs and cost-effective drug delivery system are estimated to foster the growth of North America opioid industry over the next seven years. In addition, increasing number of activities such as acquisitions and collaborations by industry participants is anticipated to fuel market demand for opioid medicines, particularly in North America region. The North America opioid market is predicted to grow at CAGR of 4.6% in the forecast period, providing numerous opportunities for market players to invest for research and development in the market. Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/north-america-opioid-market/request-sample Application Outlook:
Pain Relief o Cancer Pain o Post-operative Pain Management o Low Back Pain o Orthopedic o Neuropathic Pain o Fibromyalgia Anesthesia Cough Suppression Diarrhea suppression De - addiction
Pain relief medicines, which are gaining popularity in the pharmaceutical & medicine sector, use nonopioid, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).These drugs does not carry the risk of developing drug dependency. However, regular use of these drugs for pain relief leads to ceiling effect in patients, thus restraining market growth to a certain extent. Yet, development novel drugs such as buprenorphine, fentanyl, and morphine for pain management are predicted to stimulate market demand over the next seven years. Regional Outlook: North America opioid market is broadly categorized into five major segments based on the application type such as pain relief, anesthesia, cough suppression, diarrhea suppression and de-addiction. The pain relief is considered as one of the fastest growing segment in the North America opioid industry with substantial revenue generation in the last few years. Growing popularity of opioid drugs in the pain relief segment is attributed to the rising preference towards opioid drugs by healthcare professional and higher market penetration. The cough suppression segment has also witnessed substantial growth owing to the cost efficiency and easy availability. North America region has shown exponential growth in opioid market in the last few years owing to the rise in the implementation of latest technologies in pharmaceutical sector, increase in the number of research & development activities in the region, and existence of well-established healthcare infrastructure. Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/
Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com
Global Headquarters
Asia Pacific
Million Insights
Million Insights
410 E Santa Clara Street,
Office No. 302, 3rd Floor, Manikchand Galleria,
Unit #1008 San Jose, CA, 95113, United States
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 1-408-610-2300 Email: sales@millioninsights.com
Phone: +91-8956380892 Email: sales@millioninsights.com